Quick Answer
BriaCell Therapeutics Corp. reported Stockholders Equity of $17.33 million for fiscal year 2025.
BriaCell Therapeutics Corp. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $17.33M | +745.6% |
| 2024 | -$2.68M | +28.9% |
| 2023 | -$3.78M | -136.6% |
| 2022 | $10.33M | -62.7% |
| 2021 | $27.67M | +1109.6% |
| 2020 | -$2.74M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| October 31, 2025 | $9.35M | +151.8% | -46.1% |
| July 31, 2025 | $17.33M | +745.6% | +45.2% |
| April 30, 2025 | $11.94M | +291.6% | +270.1% |
| January 31, 2025 | $3.23M | +138.8% | -13.1% |
| October 31, 2024 | $3.71M | +47.6% | +238.3% |
| July 31, 2024 | -$2.68M | +28.9% | +56.9% |
| April 30, 2024 | -$6.23M | -5.8% | +25.1% |
| January 31, 2024 | -$8.32M | -549.5% | -430.5% |
- BriaCell Therapeutics Corp. showed an increase of +745.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2020–2025 period, BriaCell Therapeutics Corp.’s stockholders equity has grown by 732.5% (from -$2.74 million to $17.33 million).
- The most recent figure is from BriaCell Therapeutics Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on October 16, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: